• Activity INFORMATION

  Overview

  In a podcast-style discussion, Mike Corvino, PharmD, and Cole Swanson, PharmD examine the American Academy of Dermatology’s updated 2024 guideline for the management of acne vulgaris. Since their most recent update in 2016, several new medications have come to market that influence their new recommendations. Acne is a very common condition and pharmacists and nurses regularly encounter patients self-treating with over-the-counter medications. It is important that pharmacists and nurses understand the appropriate use of prescription medications available to treat this condition and how to counsel patients on side effects. This session seeks to explore these topics, focusing on how this information can best be incorporated into daily medical practice.

  Access the original podcast here

  
  

  Handouts

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify significant changes to the acne management guideline since their last update in 2016

  Identify lifestyle and non-pharmacologic treatments and explore if the data supports their use

  Review strong recommendations made by the guideline related to appropriate medication therapy

  Recognize newer medication therapies mentioned in the guideline

  Recognize conditional recommendations made by the guideline and how to incorporate them into clinical practice

  Nurse

  Recognize conditional recommendations made by the guideline and how to incorporate them into clinical practice

  Identify lifestyle and non-pharmacologic treatments and explore if the data supports their use

  Identify significant changes to the acne management guideline since their last update in 2016

  Review strong recommendations made by the guideline related to appropriate medication therapy

  Recognize newer medication therapies mentioned in the guideline

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1185846

  Universal Activity Number

  Pharmacist 0798-0000-24-090-H01-P
  Nurse 0798-0000-24-090-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Coleman  Swanson, PharmD, CDCES Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy Department

  Michael  Corvino, PharmD, BCPS, BCACP, CDCES Clinical Pharmacist, Fetter Health Care Network

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).